Going Home and Returning to Daily Life After Treatment

Leaving the hospital is a milestone and also the start of a new phase of care. Acute care nurse practitioner Mary Montefusco, ACNP, of Memorial Sloan Kettering Cancer Center describes the immediate postdischarge period for people recovering from tumor-infiltrating lymphocyte (TIL) therapy. She explains why it's important to stay within about 1 hour of the treating center rather than returning to a local hospital unfamiliar with TIL, and how frequent outpatient visits help the team monitor blood counts, prevent infection, and support recovery from fatigue. Michael Goldman reflects on how quickly he returned to his normal daily life after interleukin-2 (IL-2), with minimal support needs beyond the first few days and no real impact on his day-to-day routine. Medical oncologist James Smithy, MD, MHS, notes that younger, otherwise-healthy people often have smoother recoveries, and reinforces the value of 24/7 phone and patient portal access.